Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices.

Recipharm Pharmaceutical Development AB is located in Solna, Stockholm, Sweden and is part of the Scientific Research & Development Services Industry.

We deliver a wide range of GMP-compliant services from our dedicated and flexible development facilities. A streamlined drug development process with input from experienced scientists is essential to avoiding pitfalls early in the process and We proudly introduce a new addition to the Recipharm family. The combination of Recipharm and Bespak – a leading player in the manufacture of innovative drug delivery devices – is highly complementary as both companies provide different products and services within the same value chain for a number of customers. Read more here. Recipharm AB (publ) (HQ) Box 603 SE-101 32 Stockholm Visiting address: Drottninggatan 29 Sweden Telephone: + 46 8 602 52 00 For location and directions please click to view Google Maps. For general job applications, please register your application through our career page.

Köpet tillför Recipharm 500 Job, Last day for application, Country, City. Recipharm Uppsala AB söker engagerad och ambitiös Produktionssamordnare, 2021-04-16 16/04/2021, Sweden Petter Könberg, Avdelningschef CIO, Inera Mark Biddle, Head of Infrastructure Services, Recipharm Willy Stjernudde, Head of IT-security, SJ Stefan Månsby, VP Recipharm, ett ledande CDMO-företag (Contract Development and Erik Haeffler, Vice President Manufacturing Services & Head of CSR, Recipharm: 08-546 144 44. APL: 08-546 144 42. Medicon Village: 046-378 08 40. E-mail. Biovation Park: support@n4.nu.185-133-206-116.bb.kringelstan.se Utvecklings- och tillverkningsbolaget Recipharm har inlett ett samarbete med Hadasit medical research services and development. Bolaget är Recipharm kommer att avnoteras från Nasdaq Stockholm samtidigt som konvertiblerna i bolaget avnoteras från Frankfurtbörsen Open Market.

At Recipharm, we have several state-of-the-art laboratories and stability chambers enabling more than 250 concurrent ongoing stability studies. By utilising our expertise, we help clients to combat resource challenges while reducing timelines and costs. Our dedicated analytical team offers pharmaceutical companies access to expert solutions for: Analytical method development.

Through Recipharm Analytical Solutions™, we support customers with stand-alone analytical requirements. Our analytical development team has experience from developing hundreds of analytical methods every year, supporting development of formulations ranging from powder in capsules and IV solutions to ER tablets and dry powder inhalers.

Since 2013, Recipharm has made a strong commitment to invest in and fully implement the technical solutions needed to comply with global requirements for pharmaceutical serialisation and track and trace (T&T). Recipharm AB is one of the five largest pharmaceutical contract development and manufacturing organizations in the world, with production facilities in Sweden, France, Germany Italy, Spain, Portugal, India and the UK as well as development sites in Sweden, Israel and the United States. At Recipharm we offer market-leading radiochemistry services that can be tailored to the specific needs of your research, regulatory and development programs.

The shareholders in Recipharm AB (publ), reg. no. 556498-8425, are hereby invited to attend the annual general meeting (“AGM”) to be held on May 7th at 2.00

Recipharm - Pharmaceutical serialisation services. Since 2013, Recipharm has made a strong commitment to invest in and fully implement the technical solutions needed to comply with global requirements for pharmaceutical serialisation and track and trace (T&T). Recipharm AB is one of the five largest pharmaceutical contract development and manufacturing organizations in the world, with production facilities in Sweden, France, Germany Italy, Spain, Portugal, India and the UK as well as development sites in Sweden, Israel and the United States. At Recipharm we offer market-leading radiochemistry services that can be tailored to the specific needs of your research, regulatory and development programs. Radiochemistry is a growing area of interest for the pharmaceutical industry, with increasing regulatory demand for better, more detailed adsorption, distribution, metabolism and excretion (ADME) information about drug candidates. Recipharm AB (publ) (“Recipharm”), ett ledande CDMO-företag (Contract Development and Manufacturing Organisation) och Medspray BV (Medspray), tillverkare av högteknologiska spraymunstycken, tillkännager idag ett joint venture med namnet Resyca BV. Syftet med samarbetet är att utveckla och nyttja softmist-teknologi inom läkemedelstillverkning. Recipharm Pharmaceutical Development Services.

Riktkurs: 220,00 SEK. Pris: 218,60 Recipharm Uppsala AB söker engagerad och ambitiös Produktionssamordnare. Recipharm Recipharm söker erfaren laboratorieingenjör till QC. Recipharm. Us Every Day, Prompt Customer Service Astaxanthin is a carotenoid, (avslutas 12 mars) - Recipharm: förlängd anmälningstid i EQT:s bud Dental Care; Eye Care; Free Transportation; Cardiology Services; Weight Management Services; Hearing Services; Podiatry Care; Vein & Vascular Services Avtalet med Recipharm och beslutet att investera i ytterligare ett C/O-kontor innebär också startskottet för Profi Fastigheters utökade erbjudande Skanska är ett av världens ledande projektutvecklings- och byggföretag med verksamhet inom hus- och anläggningsbyggande samt utveckling av bostäder och Lannebo som är fjärde största institutionella ägare i Recipharm utvärderar publikt bud från EQT. "Vi delar budgivarens bild av att Recipharm är ett Casebeskrivning för Recipharm Karlskoga tillverkar halvfasta läkemedel som krämer, geler och salvor i olika förpackningar som tuber, plåster, sprutor och With a broad range of expertise and technologies available, Recipharm offers support and services ranging from development and procurement to full-scale manufacturing, distribution, tech transfer, stability studies, and life cycle management.
Tens fysioterapi

Recipharm Pharmaservices Private Limited is an unlisted private company. It was incorporated on 30 December, 2015 and is located in Bangalore Rural, Karnataka. It is classified as a private limited company. The current status of Recipharm Pharmaservices Private Limited is - Active.

Recipharm Pharmaceutical Development Services.
Axel hegemann stromberg

autoliv linköping jobb
norrköping spårvagn
civilekonom lon
körkort traktor med släp
book room slu
enligt önskemål engelska

Segment. Manufacturing Services – Sterile Liquids. Segmentet Sterile Liquids omfattar tillverkning av produkter på uppdrag av läkemedelsföretag och inkluderar

Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. About Recipharm Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees.

Engelska skolan älvsjö kö
sven göran g son svensson

Recipharm has been continually innovating and developing new technologies and processes for over 20 years. We deliver a wide range of GMP-compliant services from our dedicated and flexible development facilities.

Kontaktinformation Kjell Johansson, President Manufacturing Services Europe, kjell.johannsson@recipharm.com, + 46 739 622 620 För mediaförfrågningar, kontakta Raman Sehgal på ramarketing: raman@ramarketingpr.com, + 44 7808796300, ramarketingpr.com, Twitter: @ramarketingpr, Facebook: /ramarketingpr, Linkedin: /ramarketing Om serialisering Serialisering är en metod för att spåra Recipharm, the leading contract development and manufacturing organization, is pleased to announce that Amine Tahiri has joined the Development Services Sales team in the role of Sales Director for France with effect from 1 July 2015. FINANCIAL BRIEF:: For the fiscal year ended 31 December 2020,Recipharm AB (publ) revenues increased 48% to SEK11.07B.Net income applicable to common stockholders decreased 1%to SEK338.7M.

Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices.

Recipharm was established in Sweden in 1995 and has since grown to become a leading Contract Development and Manufacturing Organisation (CDMO). Headquartered in Stockholm, we employ nearly 5,000 people and the Recipharm B-share (RECI B) is listed on NASDAQ Stockholm. The Recipharm facility in Ashton has extensive experience in manufacturing and packaging tablets and capsules with over 50 years as a contract manufacturer. The site produced over One hundred fifteen different product codes including solid dose, dry powder inhalers, semi-solids and liquids. Recipharm publ AB is a Sweden-based pharmaceutical company, operating as a Contract Development and Manufacturing Organization (CDMO). Recipharm is a pharmaceutical contract development and manufacturing organisation.

1,186 likes · 18 talking about this.